Serra MÁ - Search Results

1

SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect?

D'Marco L, Puchades MJ, Serra MÁ, Gandía L, Romero-Alcaide S, Giménez-Civera E, Molina P, Panizo N, Reque J, Gorriz JL. D'Marco L, et al. Among authors: serra ma. Int J Environ Res Public Health. 2021 May 27;18(11):5748. doi: 10.3390/ijerph18115748. Int J Environ Res Public Health. 2021. PMID: 34071948 Free PMC article.

2

Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis.

Serra MA, Puchades MJ, Rodríguez F, Escudero A, del Olmo JA, Wassel AH, Rodrigo JM. Serra MA, et al. Scand J Gastroenterol. 2004 Nov;39(11):1149-53. doi: 10.1080/00365520410008024. Scand J Gastroenterol. 2004. PMID: 15545175

3

Let's End HepC: Modelling Public Health Epidemiological Policies Applied to Hepatitis C in Spain.

Lopes H, Baptista-Leite R, Franco D, Serra MA, Escudero A, Martín-Moreno JM. Lopes H, et al. Among authors: serra ma. Front Public Health. 2022 Jan 7;9:735572. doi: 10.3389/fpubh.2021.735572. eCollection 2021. Front Public Health. 2022. PMID: 35071151 Free PMC article.

4

Successful treatment of hepatitis C virus infection with sofosbuvir and simeprevir in the early phase of an allogeneic stem cell transplant.

Piñana JL, Serra MÁ, Hernández-Boluda JC, Navarro D, Calabuig M, Solano C. Piñana JL, et al. Among authors: serra ma. Transpl Infect Dis. 2016 Feb;18(1):89-92. doi: 10.1111/tid.12474. Epub 2016 Feb 9. Transpl Infect Dis. 2016. PMID: 26485423

5

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.

Londoño MC, Riveiro-Barciela M, Ahumada A, Muñoz-Gómez R, Roget M, Devesa-Medina MJ, Serra MÁ, Navascués CA, Baliellas C, Aldamiz-Echevarría T, Gutiérrez ML, Polo-Lorduy B, Carmona I, Benlloch S, Bonet L, García-Samaniego J, Jiménez-Pérez M, Morán-Sánchez S, Castro Á, Delgado M, Gea-Rodríguez F, Martín-Granizo I, Montes ML, Morano L, Castaño MA, de Los Santos I, Laguno M, Losa JE, Montero-Alonso M, Rivero A, de Álvaro C, Manzanares A, Mallolas J, Barril G, González-Parra E, García-Buey L. Londoño MC, et al. Among authors: serra ma. PLoS One. 2019 Sep 24;14(9):e0221567. doi: 10.1371/journal.pone.0221567. eCollection 2019. PLoS One. 2019. PMID: 31550267 Free PMC article.

6

Prevalence of liver disease and infection by hepatitis B, delta virus, and human immunodeficiency virus in two Spanish penitentiaries.

del Olmo JA, Llovet F, Rodrigo JM, Molina J, Aparisi L, Serra MA, Wassel A, Bixquert MA. del Olmo JA, et al. Among authors: serra ma. Med Microbiol Immunol. 1990;179(1):43-8. doi: 10.1007/BF00190149. Med Microbiol Immunol. 1990. PMID: 2329961

7

Effect of hepatitis C virus infection and abstinence from alcohol on survival in patients with alcoholic cirrhosis.

Serra MA, Escudero A, Rodríguez F, del Olmo JA, Rodrigo JM. Serra MA, et al. J Clin Gastroenterol. 2003 Feb;36(2):170-4. doi: 10.1097/00004836-200302000-00016. J Clin Gastroenterol. 2003. PMID: 12544203

8

Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage.

Serra MA, Rodríguez F, del Olmo JA, Escudero A, Rodrigo JM. Serra MA, et al. J Viral Hepat. 2003 May;10(3):183-8. doi: 10.1046/j.1365-2893.2003.00372.x. J Viral Hepat. 2003. PMID: 12753336

9

Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection.

Perelló C, Carrión JA, Ruiz-Antorán B, Crespo J, Turnes J, Llaneras J, Lens S, Delgado M, García-Samaniego J, García-Paredes F, Fernández I, Morillas RM, Rincón D, Porres JC, Prieto M, Lázaro Ríos M, Fernández-Rodríguez C, Hermo JA, Rodríguez M, Herrero JI, Ruiz P, Fernández JR, Macías M, Pascasio JM, Moreno JM, Serra MÁ, Arenas J, Real Y, Jorquera F, Calleja JL; Spanish Collaborative Group for the Study of the Use of Hepatitis C Direct-Acting Drugs. Perelló C, et al. Among authors: serra ma. J Viral Hepat. 2017 Mar;24(3):226-237. doi: 10.1111/jvh.12637. Epub 2016 Dec 15. J Viral Hepat. 2017. PMID: 27976491

10

[The hepatitis C virus among the prison population of Valencia].

Añón C, del Olmo JA, Llovet F, Serra MA, Gilabert S, Rodríguez F, Rodrigo JM. Añón C, et al. Among authors: serra ma. Rev Esp Enferm Dig. 1995 Jul;87(7):505-8. Rev Esp Enferm Dig. 1995. PMID: 7662418 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page